Stereotactic Body Radiotherapy With or Without Darolutamide for OligoRecurrent Prostate Cancer

NCT04641078 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer
Prostate Cancer Recurrent
Prostate Cancer Metastatic
Metastatic Cancer
Oligometastasis

Interventions

DRUG: Darolutamide
RADIATION: metastasis-directed treatment

Sponsor

University Hospital, Ghent